SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-21-012523
Filing Date
2021-03-11
Accepted
2021-03-11 16:18:02
Documents
84
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K achv-10k_20201231.htm 10-K 3602976
2 EX-21.1 achv-ex211_12.htm EX-21.1 2047
3 EX-23.1 achv-ex231_10.htm EX-23.1 2637
4 EX-31.1 achv-ex311_7.htm EX-31.1 8187
5 EX-31.2 achv-ex312_8.htm EX-31.2 9079
6 EX-32.1 achv-ex321_11.htm EX-32.1 4192
7 EX-32.2 achv-ex322_6.htm EX-32.2 4278
  Complete submission text file 0001564590-21-012523.txt   13166610

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT achv-20201231.xml EX-101.INS 3144379
9 XBRL TAXONOMY EXTENSION SCHEMA achv-20201231.xsd EX-101.SCH 88598
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE achv-20201231_cal.xml EX-101.CAL 59169
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE achv-20201231_def.xml EX-101.DEF 331986
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE achv-20201231_lab.xml EX-101.LAB 639532
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE achv-20201231_pre.xml EX-101.PRE 502786
Mailing Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101
Business Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 033-80623 | Film No.: 21733526
SIC: 2835 In Vitro & In Vivo Diagnostic Substances